Link to this page
Medical Subject Headings
Last uploaded:
March 22, 2026
| Id | http://purl.bioontology.org/ontology/MESH/C000726810
http://purl.bioontology.org/ontology/MESH/C000726810
|
|---|---|
| Preferred Name | vecabrutinib |
| Synonyms |
(3R,4S)-1-(6-amino-5-fluoropyrimidin-4-yl)-3-((3R)-3-(3-chloro-5-(trifluoromethyl)anilino)-2-oxopiperidin-1-yl)piperidine-4-carboxamide
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| altLabel | (3R,4S)-1-(6-amino-5-fluoropyrimidin-4-yl)-3-((3R)-3-(3-chloro-5-(trifluoromethyl)anilino)-2-oxopiperidin-1-yl)piperidine-4-carboxamide
|
|---|---|
| prefLabel | vecabrutinib
|
| Scope Statement | Bruton tyrosine kinase (BTK) inhibitor
|
| type | |
| tui |
T116
T129
T121
|
| HM |
D010880
D000814
|
| SC | 1
|
| TERMUI |
T001132865
T001132866
|
| TH |
NLM (2023)
USAN (19XX)
INN (19XX)
|
| SRC | Blood. 2022 Feb 10;139(6):859-875.
|
| MMR | 20230213
|
| notation | C000726810
|
| Semantic type UMLS property | |
| cui | C4682414
|
| DSC | 20230213
|
| Inverse of RB | PQ7O0OB5GU
|
| Mapped to | |
| MDA | 20230213
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |